In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections

Authors
Watanabe, A Torue, Y Takahashi, H Kikuchi, T Kobayashi, T Gomi, K Fujimura, S Nukiwa, T
Citation
A. Watanabe et al., In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections, ANTIM AG CH, 43(7), 1999, pp. 1767-1768
Citations number
6
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
43
Issue
7
Year of publication
1999
Pages
1767 - 1768
Database
ISI
SICI code
0066-4804(199907)43:7<1767:IVAOHA>2.0.ZU;2-5
Abstract
The in vitro activity of HSR-903, an oral quinolone, against 196 recent cli nical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against S taphylococcus aureus, including methicillin-resistant strains, and Streptoc occus pneumoniae and was at least as active as the other quinolones against gram-negative pathogens.